The dexamethasone suppression test: identification of subtypes of depression. 1983

A F Schatzberg, and A J Rothschild, and J B Stahl, and T C Bond, and A H Rosenbaum, and S B Lofgren, and R A MacLaughlin, and M A Sullivan, and J O Cole

In this study mean 4 p.m. cortisol levels were significantly higher in patients with major depression than in control subjects or in patients with bipolar depression or dysthymic-related disorders. Moreover, the distribution of values differed significantly among groups. Eighteen of 45 patients with major depression had cortisol levels of 10 micrograms/dl or more, compared with 2 of 20 bipolar depressed patients and 0 of 31 controls. Patients with very high cortisol levels (15 micrograms/dl or more) tended to fulfill criteria for major depression with mood-congruent psychosis. The distribution of values in the major depression group also suggested the existence of three major subgroups. The authors discuss the implications of these data.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D003866 Depressive Disorder An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent. Depression, Endogenous,Depression, Neurotic,Depression, Unipolar,Depressive Syndrome,Melancholia,Neurosis, Depressive,Unipolar Depression,Depressions, Endogenous,Depressions, Neurotic,Depressions, Unipolar,Depressive Disorders,Depressive Neuroses,Depressive Neurosis,Depressive Syndromes,Disorder, Depressive,Disorders, Depressive,Endogenous Depression,Endogenous Depressions,Melancholias,Neuroses, Depressive,Neurotic Depression,Neurotic Depressions,Syndrome, Depressive,Syndromes, Depressive,Unipolar Depressions
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006854 Hydrocortisone The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. Cortef,Cortisol,Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-,11-Epicortisol,Cortifair,Cortril,Epicortisol,Hydrocortisone, (11 alpha)-Isomer,Hydrocortisone, (9 beta,10 alpha,11 alpha)-Isomer,11 Epicortisol
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A F Schatzberg, and A J Rothschild, and J B Stahl, and T C Bond, and A H Rosenbaum, and S B Lofgren, and R A MacLaughlin, and M A Sullivan, and J O Cole
January 1985, Psychopathology,
A F Schatzberg, and A J Rothschild, and J B Stahl, and T C Bond, and A H Rosenbaum, and S B Lofgren, and R A MacLaughlin, and M A Sullivan, and J O Cole
January 1986, Actas luso-espanolas de neurologia, psiquiatria y ciencias afines,
A F Schatzberg, and A J Rothschild, and J B Stahl, and T C Bond, and A H Rosenbaum, and S B Lofgren, and R A MacLaughlin, and M A Sullivan, and J O Cole
March 1982, Journal of affective disorders,
A F Schatzberg, and A J Rothschild, and J B Stahl, and T C Bond, and A H Rosenbaum, and S B Lofgren, and R A MacLaughlin, and M A Sullivan, and J O Cole
January 1981, Psychopharmacology bulletin,
A F Schatzberg, and A J Rothschild, and J B Stahl, and T C Bond, and A H Rosenbaum, and S B Lofgren, and R A MacLaughlin, and M A Sullivan, and J O Cole
January 1982, Biological psychiatry,
A F Schatzberg, and A J Rothschild, and J B Stahl, and T C Bond, and A H Rosenbaum, and S B Lofgren, and R A MacLaughlin, and M A Sullivan, and J O Cole
April 1980, Lancet (London, England),
A F Schatzberg, and A J Rothschild, and J B Stahl, and T C Bond, and A H Rosenbaum, and S B Lofgren, and R A MacLaughlin, and M A Sullivan, and J O Cole
January 1985, Journal of affective disorders,
A F Schatzberg, and A J Rothschild, and J B Stahl, and T C Bond, and A H Rosenbaum, and S B Lofgren, and R A MacLaughlin, and M A Sullivan, and J O Cole
August 1983, Journal of the American Geriatrics Society,
A F Schatzberg, and A J Rothschild, and J B Stahl, and T C Bond, and A H Rosenbaum, and S B Lofgren, and R A MacLaughlin, and M A Sullivan, and J O Cole
March 1983, Clinical neuropharmacology,
A F Schatzberg, and A J Rothschild, and J B Stahl, and T C Bond, and A H Rosenbaum, and S B Lofgren, and R A MacLaughlin, and M A Sullivan, and J O Cole
October 1984, Pennsylvania medicine,
Copied contents to your clipboard!